Back to top
more

Accuray (ARAY)

(Real Time Quote from BATS)

$2.03 USD

2.03
943,224

0.00 (0.00%)

Updated Nov 7, 2024 12:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 251)

Industry: Medical - Instruments

Zacks News

Cogentix Medical (CGNT) Looks Good: Stock Adds 13.3% in Session

The shares of Cogentix Medical (CGNT) rose over 13% yesterday after reports surfaced that the company is going to be acquired by Laborie Medical Technologies.

    Why Is Accuray (ARAY) Down 8% Since its Last Earnings Report?

    Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      AmerisourceBergen (ABC) Beats on Q1 Earnings, FY18 View Up

      Strong Growth in Pharmaceutical Distribution Segment and World Courier business drove AmerisourceBergen (ABC) in Q1.

        Becton, Dickinson (BDX) Beats on Q1 Earnings, Guidance Solid

        Strong growth in BD Medical and BD Life sciences segments drove Becton, Dickinson's (BD) top line in Q1.

          athenahealth (ATHN) Tops Earnings & Revenue Estimates in Q4

          Strong growth in Business and Services segment drove athenahealth's (ATHN) top line in Q4.

            Pacific Biosciences (PACB) Q4 Loss Narrows, Consumables Up

            Pacific Biosciences' (PACB) consumable revenue platform proves a vital growth-driver in Q4. Sales momentum in China remains robust.

              Quest Diagnostics (DGX) Tops Q4 Earnings, 2018 View Strong

              Quest Diagnostics' (DGX) year-over-year revenue improvement in Q4 came on the back of successful execution of its two-point strategy of accelerating growth and driving operational excellence.

                Boston Scientific (BSX) Q4 Earnings In Line, Revenues Top

                In Q4, Boston Scientific (BSX) registers balanced growth across all business lines and geographies.

                  Conmed (CNMD) Beats Earnings and Revenue Estimates in Q4

                  Conmed (CNMD) benefits from impressive general surgery performance and enhanced innovation in Q4.

                    McKesson (MCK) Beats on Q3 Earnings & Revenues, Ups '18 View

                    Strong Performance in Distribution Solutions segment drives McKesson (MCK) in Q3. An impressive FY18 outlook instills investor's optimism.

                      Baxter (BAX) Beats on Q4 Earnings & Revenues, '18 View Solid

                      Strong performance in the Hospital Products and Renal Products segments drives Baxter (BAX) in Q4.

                        IDEXX Laboratories (IDXX) Beats on Q4 Earnings and Revenues

                        IDEXX (IDXX) rides high on strength in CAG business in Q4. A raised guidance buoys optimism.

                          4 Reasons Why You Should Buy Accuray (ARAY) Stock Right Now

                          Accuray (ARAY) rides high on its Radixact platform and latest software overhaul.

                            Zacks.com highlights: Accuray, Berkshire Hills Bancorp, A. Schulman, Sysco and Tailored Brands

                            Zacks.com highlights: Accuray, Berkshire Hills Bancorp, A. Schulman, Sysco and Tailored Brands

                              QIAGEN (QGEN) Beats on Q4 Earnings and Revenues, Issues View

                              QIAGEN's (QGEN) year-over-year growth in Q4 revenues is encouraging. Expansion in operating margin buoys optimism.

                                Thermo Fisher (TMO) Q4 Earnings Beat on Growth in All Lines

                                Thermo Fisher (TMO) registers a solid international performance in Q4 with strong year-over-year growth in the Asia-Pacific and the emerging markets of China, South Korea and the Middle East.

                                  Stryker (SYK) Beats Earnings and Revenue Estimates in Q4

                                  Stryker's (SYK) Q4 results benefit from Mako product platform and higher organic sales.

                                    Illumina (ILMN) Tops Q4 Earnings & Revenues, Issues Guidance

                                    Illumina (ILMN) gains from strength in sequencing consumables and instruments as well as microarray portfolios in Q4.

                                      Align Technology (ALGN) Q4 Earnings Top on Invisalign Sales

                                      Align Technology (ALGN) gains on solid contributions from the Clear Aligner as well as Scanner and Service segments in Q4.

                                        Zimmer Biomet (ZBH) Q4 Earnings Meet Estimates, Sales Beat (Revised)

                                        Zimmer Biomet (ZBH) rides high on Hip and S.E.T segments in Q4.

                                          Hill-Rom (HRC) Beats Q1 Earnings and Revenues, Margins Up

                                          Hill-Rom (HRC) rides on strength in Front Line Care and Surgical Solutions segments in Q1.

                                            Abaxis (ABAX) Beats Earnings and Revenue Estimates in Q3

                                            Abaxis (ABAX) Q3 earnings gain on strength in Medical and Veterinary segments.

                                              Accuray (ARAY) Q2 Loss Narrower Than Estimates, Revenues Top

                                              Radixact System and major software overhaul drive Accuray (ARAY) in Q2.

                                                Varian Gains Ground on New Applications, Grows in Australia

                                                Varian's (VAR) innovative product pipeline will continue to drive growth over the long term.

                                                  Varian to Open Facility in Brazil, Global Growth in Focus

                                                  Varian's (VAR) strong overseas presence is likely to fortify its foothold in the emerging markets. The recent initiative would boost its presence in Latin America.